Our results show that TIMP1 promotes the occurrence and development of GC, which is consistent with previous reports about TIMP1 as an oncogene in other cancers, including breast cancer [24], colon cancer [10], glioblastoma [25], and non-small cell lung cancer [26]. This evidence concerns the gene TIMP1 and breast cancer.